Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-02
DOI
10.3389/fonc.2021.658552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
- (2020) Sara M Tolaney et al. LANCET ONCOLOGY
- The NFκB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
- (2020) Irida Kastrati et al. MOLECULAR CANCER RESEARCH
- Pharmacological disruption of the Notch transcription factor complex
- (2020) Rajwinder Lehal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer
- (2019) Amy S. Clark et al. CLINICAL CANCER RESEARCH
- Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
- (2019) Yu Toyoda et al. Frontiers in Pharmacology
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor
- (2019) Kamal Ahmed et al. CANCER LETTERS
- Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics
- (2019) Natalia A. Riobo-Del Galdo et al. Cells
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19
- (2019) Pengfei Zheng et al. HISTOCHEMISTRY AND CELL BIOLOGY
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors
- (2019) Emily A. Irey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis
- (2019) Na Yao et al. ONCOGENE
- Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
- (2019) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
- (2019) Priyanka Bhateja et al. Cancers
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
- (2019) Yu‑Xin Liao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy
- (2019) Matthew J. Haney et al. Journal of Neuroimmune Pharmacology
- The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer
- (2019) Michela Pasello et al. SEMINARS IN CANCER BIOLOGY
- Wnt/β-Catenin Pathway-Regulated Fibromodulin Expression Is Crucial for Breast Cancer Metastasis and Inhibited by Aspirin
- (2019) Fahim Ullah Khan et al. Frontiers in Pharmacology
- Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
- (2019) Marta Pérez-Hernández et al. Cancers
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
- (2019) Rashmi K. Murthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications
- (2018) Daiki Hira et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer
- (2018) Jin-Won Lee et al. CANCER SCIENCE
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
- (2018) Ernestina De Francesco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer
- (2018) Huaying Dong et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1
- (2018) Ruoming Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer
- (2018) Akimitsu Yamada et al. MOLECULAR CANCER RESEARCH
- TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways
- (2018) Yuanyuan Zhao et al. Molecular Oncology
- Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
- (2018) Lina Liu et al. MOLECULAR THERAPY
- Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival
- (2018) Andrew Baker et al. ONCOGENE
- A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy
- (2018) William W. Du et al. ONCOGENE
- The Hippo pathway in normal development and cancer
- (2018) Marcello Maugeri-Saccà et al. PHARMACOLOGY & THERAPEUTICS
- Functional role of circular RNAs in cancer development and progression
- (2018) Wei Lun Ng et al. RNA Biology
- miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells
- (2018) Danni Chen et al. Cell Death & Disease
- MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
- (2018) Yaming Li et al. Cell Death & Disease
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
- (2018) C Massard et al. ANNALS OF ONCOLOGY
- ABC transporters as cancer drivers: Potential functions in cancer development
- (2018) Alice Domenichini et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts
- (2018) Michael Mc Kenna et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1
- (2018) Haishan Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer
- (2018) Jie Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
- (2018) Huaying Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier
- (2018) Martin Bauer et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells
- (2018) Ying-Tzu Chang et al. PHYTOMEDICINE
- Breast cancer stem cells: Features, key drivers and treatment options
- (2018) Jürgen Dittmer SEMINARS IN CANCER BIOLOGY
- Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades
- (2018) Miglė Paškevičiūtė et al. Drug Delivery and Translational Research
- Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer
- (2018) Leisha A. Emens et al. JAMA Oncology
- Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents
- (2018) Rajendran JC Bose et al. ACS Nano
- Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
- (2018) Marco Cordani et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
- (2018) Chien-Chun Steven Pai et al. JOURNAL OF CLINICAL INVESTIGATION
- The pro-metastasis effect of circANKS1B in breast cancer
- (2018) Kaixuan Zeng et al. Molecular Cancer
- Enhancing chemosensitivity of breast cancer stem cells by down regulating SOX2 and ABCG2 using Wedelolactone-encapsulated nanoparticles
- (2018) Sreemanti Das et al. MOLECULAR CANCER THERAPEUTICS
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities
- (2018) Piao Huang et al. PHARMACOLOGY & THERAPEUTICS
- Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
- (2018) Yumeng Wang et al. Cell Reports
- Targeting the Hippo Pathway for Breast Cancer Therapy
- (2018) Liqing Wu et al. Cancers
- Immunological therapy: A novel thriving area for triple-negative breast cancer treatment
- (2018) Xiangyu Wang et al. CANCER LETTERS
- Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer
- (2018) Yun-Kai Zhang et al. CANCER LETTERS
- miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy
- (2017) Ruth Rodriguez-Barrueco et al. GENES & DEVELOPMENT
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted multidrug delivery system to overcome chemoresistance in breast cancer
- (2017) Yuan Tang et al. International Journal of Nanomedicine
- Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
- (2017) Deepali Waghray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
- (2017) Bernd Groner et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer
- (2017) Li Zhang et al. Scientific Reports
- Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
- (2017) Wenzhe Li et al. Scientific Reports
- PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
- (2016) Angel Guerrero-Zotano et al. CANCER AND METASTASIS REVIEWS
- Breast cancer stem cell: the roles and therapeutic implications
- (2016) Fang Yang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines
- (2016) Takaaki Oba et al. Oncotarget
- PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a -Secretase Inhibitor
- (2015) K. Wang et al. CLINICAL CANCER RESEARCH
- MRP1 and its role in anticancer drug resistance
- (2015) Jamie F. Lu et al. DRUG METABOLISM REVIEWS
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms
- (2015) Jonna Frasor et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer
- (2014) K. L. Cook et al. CLINICAL CANCER RESEARCH
- Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
- (2014) Wei Wang et al. CURRENT MEDICINAL CHEMISTRY
- Multidrug Resistance Protein 1 (MRP1, ABCC1), a “Multitasking” ATP-binding Cassette (ABC) Transporter
- (2014) Susan P. C. Cole JOURNAL OF BIOLOGICAL CHEMISTRY
- Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells
- (2014) Kumiko Oida et al. Scientific Reports
- Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
- (2013) A. Quintas-Cardama et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started